Plain-English translation of NCT07234656 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study invites kidney cancer patients who have had surgery and their partners or spouses to help researchers understand fear of cancer recurrence—a very common worry after treatment. You would share your thoughts and experiences to help develop better ways for doctors to ask about and support these fears during follow-up appointments.
More than half of kidney cancer patients worry about their cancer coming back, and their family members often share this fear. However, doctors don't have clear, patient-centered tools to ask about and support these worries. This research aims to create better, more personalized ways to identify and address these fears during routine cancer care.
You likely qualify if…
You likely don't qualify if…
The study has two phases. In Phase 1, a small group of patients and their partners (15 people total) will meet online or in person to discuss and help design questions about fear of cancer recurrence using a collaborative method called Design Thinking. In Phase 2, a larger group (up to 90 participants) will answer survey questions about their experiences with fear of cancer recurrence using secure digital communication from the hospital.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Denmark